← Back to patent-cliff list
Udonitrectag
Tier C — Watch / tradeUdonitrectag
Mimetech SRL
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NGFR
Indications (approved)：神经营养性角膜炎
Regional status
US
Phase II
2020-10-13
EU
Phase II
2020-10-13
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Udonitrectag?
Approved indications include: 神经营养性角膜炎.
When does the Udonitrectag patent expire?
No public expiry year is available for Udonitrectag yet; this page updates once verified.
How do I get a quote for Udonitrectag intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06